ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135880 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135880; 2) Community: the network communities that were significantly associated with the response to NSC 135880; 3) Molecule: the relationships between components within communities and NSC 135880; 4) MDR: the compounds that were significantly associated with the NSC 135880.

NSC Compound Enrichment Correlation
NSC 732859 2-chloro-1-(benzenesulfonyl)piperidine-4-carboxilic acid biphenylamide. 0.0297837393005855 0.20627048
NSC 123528 Alanine, 3-[(p-methoxy-.alpha.,.alpha.-diphenylbenzyl)thio]-, hydrate [4:1] 0.0297837393005856 0.22310157
NSC 13151 Null 0.0297837393005856 0.47353735
NSC 23925 Null 0.0297837393005856 0.039350532
NSC 303861 L-Cysteine analog 0.0297837393005856 0.40384875
NSC 321240 Null 0.0297837393005856 0.30259505
NSC 328477 3'-Chloro-3-nitro-o-salicylotoluidide 0.0297837393005856 0.22887597
NSC 339137 PHYSALOLACTONE 0.0297837393005856 0.41528822
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0297837393005856 0.34415286
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0297837393005856 0.26165505
Total:113  Current:75    [First] [Prev] [Next] [Last]